Byhealth Co., Ltd

SZSE:300146 Voorraadrapport

Marktkapitalisatie: CN¥21.6b

Byhealth Toekomstige groei

Future criteriumcontroles 4/6

Byhealth is forecast to grow earnings and revenue by 37.7% and 14.1% per annum respectively. EPS is expected to grow by 37.6% per annum. Return on equity is forecast to be 12.3% in 3 years.

Belangrijke informatie

37.7%

Groei van de winst

37.6%

Groei van de winst per aandeel

Personal Products winstgroei26.4%
Inkomstengroei14.1%
Toekomstig rendement op eigen vermogen12.3%
Dekking van analisten

Good

Laatst bijgewerkt29 Oct 2024

Recente toekomstige groei-updates

Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 23
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Recent updates

Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement

Sep 30
Byhealth Co., Ltd (SZSE:300146) Surges 32% Yet Its Low P/E Is No Reason For Excitement

Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends

Sep 22
Byhealth (SZSE:300146) Will Want To Turn Around Its Return Trends

Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade

Aug 11
Things Look Grim For Byhealth Co., Ltd (SZSE:300146) After Today's Downgrade

Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel

Jul 26
Investors Don't See Light At End Of Byhealth Co., Ltd's (SZSE:300146) Tunnel

Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital

May 23
Byhealth (SZSE:300146) Could Be Struggling To Allocate Capital

We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings

Mar 25
We Think That There Are Issues Underlying Byhealth's (SZSE:300146) Earnings

Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 23
Byhealth Co., Ltd (SZSE:300146) Just Reported Earnings, And Analysts Cut Their Target Price

Winst- en omzetgroeiprognoses

SZSE:300146 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20269,8031,6441,3291,5818
12/31/20258,8461,3885901,4189
12/31/20247,163818-6251,0175
9/30/20247,3587147391,046N/A
6/30/20248,4241,0929951,306N/A
3/31/20248,9451,4432231,535N/A
12/31/20239,4071,7467942,051N/A
9/30/20239,4841,8056661,938N/A
6/30/20239,2371,8838182,075N/A
3/31/20238,6891,7521,8332,090N/A
12/31/20227,8611,3861,1341,379N/A
9/30/20227,5631,5731,4041,645N/A
6/30/20227,4541,4311,1701,430N/A
3/31/20227,4891,6011,4681,721N/A
12/31/20217,4311,7541,5561,819N/A
9/30/20217,0911,7201,0001,267N/A
6/30/20217,1681,9341,2991,534N/A
3/31/20216,8221,8061,2361,573N/A
12/31/20206,0951,5241,2451,566N/A
9/30/20205,914-801,7332,039N/A
6/30/20205,417-2611,4851,821N/A
3/31/20205,186-3191,3191,576N/A
12/31/20195,262-3561,2051,537N/A
9/30/20195,3101,1328801,192N/A
6/30/20195,1511,1619741,238N/A
3/31/20194,8541,1259051,234N/A
12/31/20184,3519991,0981,349N/A
9/30/20184,1821,0189681,226N/A
6/30/20183,794885N/A1,084N/A
3/31/20183,442852N/A951N/A
12/31/20173,111763N/A954N/A
9/30/20172,747771N/A809N/A
6/30/20172,562759N/A772N/A
3/31/20172,389594N/A694N/A
12/31/20162,309535N/A685N/A
9/30/20162,398619N/A710N/A
6/30/20162,322577N/A583N/A
3/31/20162,344655N/A613N/A
12/31/20152,266635N/A635N/A
9/30/20152,101609N/A606N/A
6/30/20151,944566N/A624N/A
3/31/20151,806530N/A572N/A
12/31/20141,705503N/A561N/A
9/30/20141,704547N/A674N/A
6/30/20141,668542N/A764N/A
3/31/20141,594481N/A707N/A
12/31/20131,482422N/A627N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 300146's forecast earnings growth (37.7% per year) is above the savings rate (2.9%).

Winst versus markt: 300146's earnings (37.7% per year) are forecast to grow faster than the CN market (25.8% per year).

Hoge groeiwinsten: 300146's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 300146's revenue (14.1% per year) is forecast to grow faster than the CN market (14% per year).

Hoge groei-inkomsten: 300146's revenue (14.1% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 300146's Return on Equity is forecast to be low in 3 years time (12.3%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y